Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-15
2011-11-01
Dentz, Bernard (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S404000
Reexamination Certificate
active
08048912
ABSTRACT:
The present invention relates to a novel benzopyran derivative having goodantagonistic activity on TGF-β receptor which can be effectively used as a prophylactic and therapeutic agent for liver disease as well as several fibroplasiadiseases such as hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, dermatosclerosis, glomerular fibrosis and the like; and a pharmaceutical use thereof.
REFERENCES:
patent: 4681890 (1987-07-01), Kanehira et al.
patent: 5703075 (1997-12-01), Gammill et al.
patent: 5763470 (1998-06-01), Tang et al.
patent: 6492390 (2002-12-01), Carter et al.
Cho Yong-Baik
Dong Mi-Sook
Gong Young-Dae
Jeon Moon-Kook
Kim Jeong-Ran
Dentz Bernard
Frommer & Lawrence & Haug LLP
Korea Research Institute of Chemical Technology
Santucci Ronald R.
SK Chemicals Co. Ltd.
LandOfFree
Benzopyran derivatives having inhibitory activities against... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzopyran derivatives having inhibitory activities against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyran derivatives having inhibitory activities against... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298909